메뉴 건너뛰기




Volumn 134, Issue 11, 2014, Pages 2683-2690

Insulin-like growth factor i and risk of breast cancer by age and hormone receptor status - A prospective study within the EPIC cohort

(44)  Kaaks, Rudolf a   Johnson, Theron a   Tikk, Kaja a   Sookthai, Disorn a   Tjønneland, Anne b   Roswall, Nina b   Overvad, Kim c   Clavel Chapelon, Françoise d,e,f   Boutron Ruault, Marie Christine d,e,f   Dossus, Laure d,e,f   Rinaldi, Sabina g   Romieu, Isabelle g   Boeing, Heiner h   Schütze, Madlen h   Trichopoulou, Antonia i,j   Lagiou, Pagona i,k,l   Trichopoulos, Dimitrios j,k,l   Palli, Domenico m   Grioni, Sara n   Tumino, Rosario o   more..

f IGR   (France)

Author keywords

breast cancer; estrogen receptor; European Prospective Investigation into Cancer and Nutrition; insulin like growth factor I; prospective cohort

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; SOMATOMEDIN C;

EID: 84896400782     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28589     Document Type: Article
Times cited : (55)

References (50)
  • 1
    • 51649091930 scopus 로고    scopus 로고
    • Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
    • Creighton CJ, Casa A, Lazard Z, et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008; 26: 4078-85.
    • (2008) J Clin Oncol , vol.26 , pp. 4078-4085
    • Creighton, C.J.1    Casa, A.2    Lazard, Z.3
  • 2
    • 0028958031 scopus 로고
    • Insulin-like growth factors and their binding proteins: Biological actions
    • Jones JI, Clemmons DR,. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
    • (1995) Endocr Rev , vol.16 , pp. 3-34
    • Jones, J.I.1    Clemmons, D.R.2
  • 3
    • 0242594016 scopus 로고    scopus 로고
    • The IGF-1 receptor in cancer biology
    • Baserga R, Peruzzi F, Reiss K,. The IGF-1 receptor in cancer biology. Int J Canc 2003; 107: 873-7.
    • (2003) Int J Canc , vol.107 , pp. 873-877
    • Baserga, R.1    Peruzzi, F.2    Reiss, K.3
  • 4
    • 0032499440 scopus 로고    scopus 로고
    • Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
    • Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-6.
    • (1998) Lancet , vol.351 , pp. 1393-1396
    • Hankinson, S.E.1    Willett, W.C.2    Colditz, G.A.3
  • 5
    • 34247534611 scopus 로고    scopus 로고
    • Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer
    • Baglietto L, English DR, Hopper JL, et al. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Canc Epidemiol Biomark Prev 2007; 16: 763-8.
    • (2007) Canc Epidemiol Biomark Prev , vol.16 , pp. 763-768
    • Baglietto, L.1    English, D.R.2    Hopper, J.L.3
  • 6
    • 77953536809 scopus 로고    scopus 로고
    • Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies
    • Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530-42.
    • (2010) Lancet Oncol , vol.11 , pp. 530-542
    • Key, T.J.1    Appleby, P.N.2    Reeves, G.K.3
  • 7
    • 0037869234 scopus 로고    scopus 로고
    • Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer
    • Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, et al. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Canc 2003; 106: 90-5.
    • (2003) Int J Canc , vol.106 , pp. 90-95
    • Keinan-Boker, L.1    Bueno De Mesquita, H.B.2    Kaaks, R.3
  • 8
    • 33745104067 scopus 로고    scopus 로고
    • IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
    • Rinaldi S, Peeters PH, Berrino F, et al. IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Canc 2006; 13: 593-605.
    • (2006) Endocr Relat Canc , vol.13 , pp. 593-605
    • Rinaldi, S.1    Peeters, P.H.2    Berrino, F.3
  • 9
    • 16844374390 scopus 로고    scopus 로고
    • Circulating levels of Insulin-like Growth Factors, their binding proteins, and breast cancer risk
    • Schernhammer ES, Holly JM, Pollak MN, et al. Circulating levels of Insulin-like Growth Factors, their binding proteins, and breast cancer risk. Canc Epidemiol Biomark Prev 2005; 14: 699-704.
    • (2005) Canc Epidemiol Biomark Prev , vol.14 , pp. 699-704
    • Schernhammer, E.S.1    Holly, J.M.2    Pollak, M.N.3
  • 10
    • 1942436958 scopus 로고    scopus 로고
    • Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis
    • Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-53.
    • (2004) Lancet , vol.363 , pp. 1346-1353
    • Renehan, A.G.1    Zwahlen, M.2    Minder, C.3
  • 11
    • 3242884950 scopus 로고    scopus 로고
    • IGF-I and breast cancer: A meta-analysis
    • Shi R, Yu H, McLarty J, et al. IGF-I and breast cancer: a meta-analysis. Int J Canc 2004; 111: 418-23.
    • (2004) Int J Canc , vol.111 , pp. 418-423
    • Shi, R.1    Yu, H.2    McLarty, J.3
  • 12
    • 3142726250 scopus 로고    scopus 로고
    • Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: A meta-analysis of literature
    • Sugumar A, Liu YC, Xia Q, et al. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Canc 2004; 111: 293-7.
    • (2004) Int J Canc , vol.111 , pp. 293-297
    • Sugumar, A.1    Liu, Y.C.2    Xia, Q.3
  • 13
    • 0036912055 scopus 로고    scopus 로고
    • Insulin-like growth factor i (IGF-I), IGF-binding proteins, and breast cancer
    • Krajcik RA, Borofsky ND, Massardo S, et al. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Canc Epidemiol Biomark Prev 2002; 11: 1566-73.
    • (2002) Canc Epidemiol Biomark Prev , vol.11 , pp. 1566-1573
    • Krajcik, R.A.1    Borofsky, N.D.2    Massardo, S.3
  • 14
    • 0035945656 scopus 로고    scopus 로고
    • Estrogen and the risk of breast cancer
    • Clemons M, Goss P,. Estrogen and the risk of breast cancer. New Eng J Med 2001; 344: 276-85.
    • (2001) New Eng J Med , vol.344 , pp. 276-285
    • Clemons, M.1    Goss, P.2
  • 15
    • 1642419529 scopus 로고    scopus 로고
    • Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
    • Stahlberg C, Pedersen AT, Lynge E, et al. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Canc 2004; 109: 721-7.
    • (2004) Int J Canc , vol.109 , pp. 721-727
    • Stahlberg, C.1    Pedersen, A.T.2    Lynge, E.3
  • 16
    • 84877875905 scopus 로고    scopus 로고
    • Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
    • Collaborative Group on Hormonal Factors in Breast Cancer.
    • Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13: 1141-51.
    • (2012) Lancet Oncol , vol.13 , pp. 1141-1151
  • 17
    • 80053912279 scopus 로고    scopus 로고
    • Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: A nested case-control study
    • James RE, Lukanova A, Dossus L, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Canc Prev Res (Phil) 2011; 4: 1626-35.
    • (2011) Canc Prev Res (Phil) , vol.4 , pp. 1626-1635
    • James, R.E.1    Lukanova, A.2    Dossus, L.3
  • 18
    • 29144464971 scopus 로고    scopus 로고
    • Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition
    • Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Canc 2005; 12: 1071-82.
    • (2005) Endocr Relat Canc , vol.12 , pp. 1071-1082
    • Kaaks, R.1    Rinaldi, S.2    Key, T.J.3
  • 19
    • 0030803940 scopus 로고    scopus 로고
    • A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey
    • Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Canc 1997; 76: 401-5.
    • (1997) Br J Canc , vol.76 , pp. 401-405
    • Thomas, H.V.1    Key, T.J.2    Allen, D.S.3
  • 20
    • 14944373265 scopus 로고    scopus 로고
    • The role of endogenous hormones in the etiology and prevention of breast cancer: The Epidemiological Evidence
    • Muti P,. The role of endogenous hormones in the etiology and prevention of breast cancer: the Epidemiological Evidence. Ann N Y Acad Sci 2004; 1028: 273-82.
    • (2004) Ann N y Acad Sci , vol.1028 , pp. 273-282
    • Muti, P.1
  • 21
    • 0033842834 scopus 로고    scopus 로고
    • Crosstalk between the insulin-like growth factors and estrogens in breast cancer
    • Yee D, Lee AV,. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5: 107-15.
    • (2000) J Mammary Gland Biol Neoplasia , vol.5 , pp. 107-115
    • Yee, D.1    Lee, A.V.2
  • 22
    • 84857915302 scopus 로고    scopus 로고
    • Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth
    • Casa A, Potter A, Malik S, et al. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth. Breast Canc Res Treat 2012; 132: 61-73.
    • (2012) Breast Canc Res Treat , vol.132 , pp. 61-73
    • Casa, A.1    Potter, A.2    Malik, S.3
  • 23
    • 79960009788 scopus 로고    scopus 로고
    • Insulin-like growth factor-1 and 17beta-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells
    • Casolari DA, Pereira MC, de Bessa Garcia SA, et al. Insulin-like growth factor-1 and 17beta-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells. Int J Mol Med 2011; 28: 337-42.
    • (2011) Int J Mol Med , vol.28 , pp. 337-342
    • Casolari, D.A.1    Pereira, M.C.2    De Bessa Garcia, S.A.3
  • 24
    • 33846846385 scopus 로고    scopus 로고
    • Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: Involvement of transcription factor Sp1
    • Maor S, Mayer D, Yarden RI, et al. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J Endocrinol 2006; 191: 605-12.
    • (2006) J Endocrinol , vol.191 , pp. 605-612
    • Maor, S.1    Mayer, D.2    Yarden, R.I.3
  • 25
    • 84884725294 scopus 로고    scopus 로고
    • A comparison of hormonal profiles between breast cancer and benign breast disease: A case-control study
    • Lagiou P, Samoli E, Lagiou A, et al. A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study. Ann Oncol 2013; 24: 2527-33.
    • (2013) Ann Oncol , vol.24 , pp. 2527-2533
    • Lagiou, P.1    Samoli, E.2    Lagiou, A.3
  • 26
    • 1542725074 scopus 로고    scopus 로고
    • Diet and cancer - The European Prospective Investigation into Cancer and Nutrition
    • Bingham S, Riboli E,. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Canc 2004; 4: 206-15.
    • (2004) Nat Rev Canc , vol.4 , pp. 206-215
    • Bingham, S.1    Riboli, E.2
  • 27
    • 0345700787 scopus 로고    scopus 로고
    • European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection
    • Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
    • (2002) Public Health Nutr , vol.5 , pp. 1113-1124
    • Riboli, E.1    Hunt, K.J.2    Slimani, N.3
  • 29
    • 0032786679 scopus 로고    scopus 로고
    • Follow-up procedures in EPIC-Germany - Data quality aspects
    • Bergmann MM, Bussas U, Boeing H,. Follow-up procedures in EPIC-Germany-data quality aspects. Ann Nutr Metab 1999; 43: 225-34.
    • (1999) Ann Nutr Metab , vol.43 , pp. 225-234
    • Bergmann, M.M.1    Bussas, U.2    Boeing, H.3
  • 30
    • 20544477209 scopus 로고    scopus 로고
    • Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)
    • Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Canc Inst 2005; 97: 755-65.
    • (2005) J Natl Canc Inst , vol.97 , pp. 755-765
    • Kaaks, R.1    Berrino, F.2    Key, T.3
  • 31
    • 0036800654 scopus 로고    scopus 로고
    • Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations
    • Rinaldi S, Geay A, Dechaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Canc Epidemiol Biomark Prev 2002; 11: 1065-71.
    • (2002) Canc Epidemiol Biomark Prev , vol.11 , pp. 1065-1071
    • Rinaldi, S.1    Geay, A.2    Dechaud, H.3
  • 32
    • 0020963636 scopus 로고
    • Tests for interaction in epidemiologic studies: A review and a study of power
    • Greenland S,. Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 1983; 2: 243-51.
    • (1983) Stat Med , vol.2 , pp. 243-251
    • Greenland, S.1
  • 33
    • 84896397455 scopus 로고    scopus 로고
    • 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins
    • Rothman KJ, Greenland S, Lash TL,. Modern epidemiology. 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2008. 279 p, 425 p.
    • (2008) Modern Epidemiology , vol.279 , pp. 425
    • Rothman, K.J.1    Greenland, S.2    Lash, T.L.3
  • 34
    • 0038237118 scopus 로고    scopus 로고
    • Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts
    • Sartorius CA, Shen T, Horwitz KB,. Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Canc Res Treat 2003; 79: 287-99.
    • (2003) Breast Canc Res Treat , vol.79 , pp. 287-299
    • Sartorius, C.A.1    Shen, T.2    Horwitz, K.B.3
  • 35
    • 0023879109 scopus 로고
    • Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines
    • Read LD, Snider CE, Miller JS, et al. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988; 2: 263-71.
    • (1988) Mol Endocrinol , vol.2 , pp. 263-271
    • Read, L.D.1    Snider, C.E.2    Miller, J.S.3
  • 36
    • 84882558986 scopus 로고    scopus 로고
    • Estrogen receptor negative/progesterone positive breast cancer is not a reproducible subtype
    • Hefti MM, Hu R, Knoblauch NW, et al. Estrogen receptor negative/progesterone positive breast cancer is not a reproducible subtype. Breast Canc Res 2013; 15: R68.
    • (2013) Breast Canc Res , vol.15
    • Hefti, M.M.1    Hu, R.2    Knoblauch, N.W.3
  • 37
    • 38349084668 scopus 로고    scopus 로고
    • Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist
    • author reply 336-8.
    • De Maeyer L, Van Limbergen E, De Nys K, et al. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist J Clin Oncol 2008; 26: 335-6. author reply 336-8.
    • (2008) J Clin Oncol , vol.26 , pp. 335-336
    • De Maeyer, L.1    Van Limbergen, E.2    De Nys, K.3
  • 38
    • 0036299562 scopus 로고    scopus 로고
    • Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: Clinical implications
    • Stoll BA,. Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. Ann Oncol 2002; 13: 191-6.
    • (2002) Ann Oncol , vol.13 , pp. 191-196
    • Stoll, B.A.1
  • 39
    • 0030670432 scopus 로고    scopus 로고
    • The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue
    • Happerfield LC, Miles DW, Barnes DM, et al. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J Pathol 1997; 183: 412-7.
    • (1997) J Pathol , vol.183 , pp. 412-417
    • Happerfield, L.C.1    Miles, D.W.2    Barnes, D.M.3
  • 40
    • 0033305004 scopus 로고    scopus 로고
    • Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
    • Lee AV, Jackson JG, Gooch JL, et al. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 1999; 13: 787-96.
    • (1999) Mol Endocrinol , vol.13 , pp. 787-796
    • Lee, A.V.1    Jackson, J.G.2    Gooch, J.L.3
  • 41
    • 0026738320 scopus 로고
    • Type 1 IGF receptor in human breast diseases
    • Peyrat JP, Bonneterre J,. Type 1 IGF receptor in human breast diseases. Breast Canc Res Treat 1992; 22: 59-67.
    • (1992) Breast Canc Res Treat , vol.22 , pp. 59-67
    • Peyrat, J.P.1    Bonneterre, J.2
  • 42
    • 0023779434 scopus 로고
    • Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors
    • Peyrat JP, Bonneterre J, Beuscart R, et al. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Canc Res 1988; 48: 6429-33.
    • (1988) Canc Res , vol.48 , pp. 6429-6433
    • Peyrat, J.P.1    Bonneterre, J.2    Beuscart, R.3
  • 43
    • 8344278838 scopus 로고    scopus 로고
    • Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women
    • Gronbaek H, Flyvbjerg A, Mellemkjaer L, et al. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Canc Epidemiol Biomark Prev 2004; 13: 1759-64.
    • (2004) Canc Epidemiol Biomark Prev , vol.13 , pp. 1759-1764
    • Gronbaek, H.1    Flyvbjerg, A.2    Mellemkjaer, L.3
  • 44
    • 31844450034 scopus 로고    scopus 로고
    • Premenopausal levels of circulating insulin-like growth factor i and the risk of postmenopausal breast cancer
    • Rollison DE, Newschaffer CJ, Tao Y, et al. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Canc 2006; 118: 1279-84.
    • (2006) Int J Canc , vol.118 , pp. 1279-1284
    • Rollison, D.E.1    Newschaffer, C.J.2    Tao, Y.3
  • 45
    • 33745069283 scopus 로고    scopus 로고
    • Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the Nurses Health Study II
    • Schernhammer ES, Holly JM, Hunter DJ, et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Canc 2006; 13: 583-92.
    • (2006) Endocr Relat Canc , vol.13 , pp. 583-592
    • Schernhammer, E.S.1    Holly, J.M.2    Hunter, D.J.3
  • 46
    • 0034748233 scopus 로고    scopus 로고
    • A cross-sectional study of IGF-I determinants in women
    • Lukanova A, Toniolo P, Akhmedkhanov A, et al. A cross-sectional study of IGF-I determinants in women. Eur J Canc Prev 2001; 10: 443-52.
    • (2001) Eur J Canc Prev , vol.10 , pp. 443-452
    • Lukanova, A.1    Toniolo, P.2    Akhmedkhanov, A.3
  • 47
    • 0348012945 scopus 로고    scopus 로고
    • Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer
    • Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Canc 2004; 108: 262-8.
    • (2004) Int J Canc , vol.108 , pp. 262-268
    • Lukanova, A.1    Zeleniuch-Jacquotte, A.2    Lundin, E.3
  • 48
    • 33644516398 scopus 로고    scopus 로고
    • Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period
    • Missmer SA, Spiegelman D, Bertone-Johnson ER, et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Canc Epidemiol Biomark Prev 2006; 15: 972-8.
    • (2006) Canc Epidemiol Biomark Prev , vol.15 , pp. 972-978
    • Missmer, S.A.1    Spiegelman, D.2    Bertone-Johnson, E.R.3
  • 49
    • 0034605463 scopus 로고    scopus 로고
    • Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
    • Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Canc Inst 2000; 92: 1592-600.
    • (2000) J Natl Canc Inst , vol.92 , pp. 1592-1600
    • Kaaks, R.1    Toniolo, P.2    Akhmedkhanov, A.3
  • 50
    • 0036892152 scopus 로고    scopus 로고
    • Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies
    • Borofsky ND, Vogelman JH, Krajcik RA, et al. Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chemistry 2002; 48: 2248-51.
    • (2002) Clin Chemistry , vol.48 , pp. 2248-2251
    • Borofsky, N.D.1    Vogelman, J.H.2    Krajcik, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.